Skip to main content

Articles

Page 3 of 53

  1. Previous studies have mainly focused more on how diabetes affects the valve than the myocardium in aortic stenosis (AS). In the pressure-overloaded heart, myocardial fibrosis is an important driver of the prog...

    Authors: Hyun-Jung Lee, Chan Soon Park, Sahmin Lee, Jun-Bean Park, Hyung-Kwan Kim, Sung-Ji Park, Yong-Jin Kim and Seung-Pyo Lee
    Citation: Cardiovascular Diabetology 2023 22:30
    Content type: Research Published on:

  2. Stress hyperglycemia ratio (SHR) is significantly related to adverse cardiovascular clinical outcomes and increased in-hospital mortality. However, the relationship between SHR and coronary artery disease (CAD...

    Authors: Yu Zhang, Haiyan Song, Jing Bai, Jiahui Xiu, Ganggang Wu, Liao Zhang, Yunhe Wu and Ying Qu
    Citation: Cardiovascular Diabetology 2023 22:29
    Content type: Research Published on:

  3. Despite paucity of data, it is common practice to discontinue metformin before invasive coronary angiography due to an alleged risk of Metformin-Associated Lactic Acidosis (M-ALA). We aimed at assessing the sa...

    Authors: Mauro Chiarito, Jorge Sanz-Sanchez, Raffaele Piccolo, Francesco Condello, Gaetano Liccardo, Matteo Maurina, Marisa Avvedimento, Damiano Regazzoli, Paolo Pagnotta, Hector M. Garcia-Garcia, Roxana Mehran, Massimo Federici, Gianluigi Condorelli, Jose Luis Diez Gil, Bernhard Reimers, Giuseppe Ferrante…
    Citation: Cardiovascular Diabetology 2023 22:28
    Content type: Research Published on:

  4. The novel sodium-glucose co-transporter 2 inhibitor (SGLT2i) potentially ameliorates heart failure and reduces cardiac arrhythmia. Cardiac fibrosis plays a pivotal role in the pathophysiology of HF and atrial ...

    Authors: Cheng-Chih Chung, Yung-Kuo Lin, Yao-Chang Chen, Yu-Hsun Kao, Yung-Hsin Yeh, Nguyen Ngoc Trang and Yi-Jen Chen
    Citation: Cardiovascular Diabetology 2023 22:27
    Content type: Research Published on:

  5. Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium glucose cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection. Whether their benefits occur also during hospitali...

    Authors: Filippo Trombara, Nicola Cosentino, Alice Bonomi, Monica Ludergnani, Paolo Poggio, Luigia Gionti, Marta Baviera, Pierluca Colacioppo, Maria Carla Roncaglioni, Olivia Leoni, Francesco Bortolan, Piergiuseppe Agostoni, Stefano Genovese and Giancarlo Marenzi
    Citation: Cardiovascular Diabetology 2023 22:26
    Content type: Research Published on:

  6. Increased acid sphingomyelinase (ASMase) activity is associated with insulin resistance and cardiac dysfunction. However, the effects of ASMase on diabetic cardiomyopathy (DCM) and the molecular mechanism(s) u...

    Authors: Ruijiao Liu, Tengfei Duan, Li Yu, Yongzhong Tang, Shikun Liu, Chunjiang Wang and Wei-Jin Fang
    Citation: Cardiovascular Diabetology 2023 22:25
    Content type: Research Published on:

  7. Sodium-glucose co-transporters (SGLT) inhibitors (SGLT2i) showed many beneficial effects at the cardiovascular level. Several mechanisms of action have been identified. However, no data on their capability to ...

    Authors: Lucia Scisciola, Fatemeh Taktaz, Rosaria Anna Fontanella, Ada Pesapane, Surina, Vittoria Cataldo, Puja Ghosh, Martina Franzese, Armando Puocci, Pasquale Paolisso, Concetta Rafaniello, Raffaele Marfella, Maria Rosaria Rizzo, Emanuele Barbato, Marc Vanderheyden and Michelangela Barbieri
    Citation: Cardiovascular Diabetology 2023 22:24
    Content type: Research Published on:

  8. Epicardial adipose tissue (EAT) plays an important role in cardiometabolic risk. EAT is a modifiable risk factor and could be a potential therapeutic target for drugs that already show cardiovascular benefits. Th...

    Authors: Veronika A. Myasoedova, Valentina Parisi, Donato Moschetta, Vincenza Valerio, Maddalena Conte, Ilaria Massaiu, Michele Bozzi, Fabrizio Celeste, Dario Leosco, Guido Iaccarino, Stefano Genovese and Paolo Poggio
    Citation: Cardiovascular Diabetology 2023 22:23
    Content type: Research Published on:

  9. Fractional Flow Reserve (FFR) is a widely applied invasive physiological assessment, endorsed by major guidelines to aid in the decision to perform or defer revascularisation. While a threshold of  > 0.8 has b...

    Authors: Avedis Ekmejian, Hari Sritharan, Dinesh Selvakumar, Venkateshka Venkateshka, Usaid Allahwala, Michael Ward and Ravinay Bhindi
    Citation: Cardiovascular Diabetology 2023 22:22
    Content type: Research Published on:

  12. Although a great deal of scientific evidence on the epidemiological risk factors for diabetes and prediabetes has been accumulated, there is still insufficient evidence to explore sex-related differences. The ...

    Authors: Yumeng Shi and Minghua Wen
    Citation: Cardiovascular Diabetology 2023 22:19
    Content type: Research Published on:

  13. Patients with concurrent atrial fibrillation (AF) and diabetes mellitus (DM) [AF-DM] have a high risk of cardiovascular and diabetes-related complications, but are less engaged in a comprehensive treatment app...

    Authors: So-Ryoung Lee, Hyo-Jeong Ahn, Eue-Keun Choi, Seung-Woo Lee, Kyung-Do Han, Seil Oh and Gregory Y. H. Lip
    Citation: Cardiovascular Diabetology 2023 22:18
    Content type: Research Published on:

  14. Type 2 Diabetes mellitus (T2DM) is a major risk factor for cardiovascular disease and associated with poor outcome after myocardial infarction (MI). In T2DM, cardiac metabolic flexibility, i.e. the switch betw...

    Authors: C. Binsch, D. M. Barbosa, G. Hansen-Dille, M. Hubert, S. M. Hodge, M. Kolasa, K. Jeruschke, J. Weiß, C. Springer, S. Gorressen, J. W. Fischer, M. Lienhard, R. Herwig, S. Börno, B. Timmermann, A. L. Cremer…
    Citation: Cardiovascular Diabetology 2023 22:17
    Content type: Research Published on:

  15. As indications for sodium-glucose co-transporter-2 inhibitors (SGLT2i) are expanding, a growing number of older adults have become candidates for treatment. We studied the safety profile of SGLT2i among older ...

    Authors: Adam Goldman, Boris Fishman, Gilad Twig, Emanuel Raschi, Tali Cukierman-Yaffe, Yonatan moshkovits, Alon Pomerantz, Ilan Ben-Zvi, Rachel Dankner and Elad Maor
    Citation: Cardiovascular Diabetology 2023 22:16
    Content type: Research Published on:

  16. To explore the additive effects of anemia on left ventricular (LV) global strains in patients with type 2 diabetes mellitus (T2DM) with or without anemia via cardiac magnetic resonance (CMR) feature tracking t...

    Authors: Wen-Lei Qian, Rong Xu, Rui Shi, Yuan Li, Ying-Kun Guo, Han Fang, Li jiang and Zhi-Gang Yang
    Citation: Cardiovascular Diabetology 2023 22:15
    Content type: Research Published on:

  17. Patients with type 2 diabetes mellitus (T2DM) are highly susceptible to cardiovascular disease, and coronary artery disease (CAD) is their leading cause of death. We aimed to assess whether computed tomography...

    Authors: Xiaolin Dong, Na Li, Chentao Zhu, Yujia Wang, Ke Shi, Hong Pan, Shuting Wang, Zhenzhou Shi, Yayuan Geng, Wei Wang and Tong Zhang
    Citation: Cardiovascular Diabetology 2023 22:14
    Content type: Research Published on:

  18. Prediction model has been the focus of studies since the last century in the diagnosis and prognosis of various diseases. With the advancement in computational technology, machine learning (ML) has become the ...

    Authors: Ooi Ting Kee, Harmiza Harun, Norlaila Mustafa, Nor Azian Abdul Murad, Siok Fong Chin, Rosmina Jaafar and Noraidatulakma Abdullah
    Citation: Cardiovascular Diabetology 2023 22:13
    Content type: Review Published on:

  19. Patients with diabetes mellitus have an increased risk of incident atrial fibrillation (AF). The effect of accumulated hypertension burden is a less well-known modifiable risk factor. We explored the relations...

    Authors: JungMin Choi, So‑Ryoung Lee, Eue‑Keun Choi, HuiJin Lee, MinJu Han, Hyo-Jeong Ahn, Soonil Kwon, Seung-Woo Lee, Kyung‑Do Han, Seil Oh and Gregory Y. H. Lip
    Citation: Cardiovascular Diabetology 2023 22:12
    Content type: Research Published on:

  20. Stress hyperglycemia ratio (SHR) is a novel biomarker of true acute hyperglycemia condition and is associated with a worse prognosis in patients with myocardial infarction (MI). However, the effects of SHR in ...

    Authors: Fuad A. Abdu, Jassur Galip, Penglong Qi, Wen Zhang, Abdul-Quddus Mohammed, Lu Liu, Guoqing Yin, Ayman A. Mohammed, Redhwan M. Mareai, Rong Jiang, Yawei Xu and Wenliang Che
    Citation: Cardiovascular Diabetology 2023 22:11
    Content type: Research Published on:

  21. The triglyceride-glucose (TyG) index is a reliable alternative biomarker of insulin resistance (IR). However, whether the TyG index has prognostic value in critically ill patients with coronary heart disease (...

    Authors: Rongting Zhang, Shanshan Shi, Weihua Chen, Yani Wang, Xueqin Lin, Yukun Zhao, Lihua Liao, Qian Guo, Xiaoying Zhang, Weiguo Li, Kaijun Zhang, Ying Liao and Yong Fang
    Citation: Cardiovascular Diabetology 2023 22:10
    Content type: Research Published on:

  22. Hypertension is a leading risk of coronary artery disease (CAD). Triglyceride glucose index (TyG) is a surrogate of insulin resistance (IR). Few studies explore the association between TyG and the incidence of...

    Authors: Weili Pan, Yongkui Ren, Fan Yang, Minxian Wang, Xinsheng Li and Da Yin
    Citation: Cardiovascular Diabetology 2023 22:9
    Content type: Research Published on:

  23. Serum selenium levels have been associated with the incidence of heart failure (HF) and signs of the metabolic syndrome. In addition, notable differences have been reported between males and females in food in...

    Authors: Eerde H. Weening, Ali A. Al-Mubarak, Martin M. Dokter, Kenneth Dickstein, Chim C. Lang, Leong L. Ng, Marco Metra, Dirk J. van Veldhuisen, Daan J. Touw, Rudolf A. de Boer, Ron T. Gansevoort, Adriaan A. Voors, Stephan J. L. Bakker, Peter van der Meer and Nils Bomer
    Citation: Cardiovascular Diabetology 2023 22:8
    Content type: Research Published on:

  24. Authors: Hai Deng, Peng Hu, Huoxing Li, Huanning Zhou, Xiuyi Wu, Maohua Yuan, Xueru Duan, Miaochan Lao, Chuchu Wu, Murui Zheng, Xiang Qian Lao, Wenjing Zhao and Xudong Liu
    Citation: Cardiovascular Diabetology 2023 22:7
    Content type: Correction Published on:

    The original article was published in Cardiovascular Diabetology 2022 21:212

  25. Previous researches on large animal models of diabetic cardiomyopathy were insufficient. The aim of this study was to evaluate early changes in left ventricular (LV) function and morphology in diabetic pigs us...

    Authors: Wei-Feng Yan, Hua-Yan Xu, Li Jiang, Lu Zhang, Ying-Kun Guo, Yuan Li, Li-Ting Shen, Chen-Yan Min and Zhi-Gang Yang
    Citation: Cardiovascular Diabetology 2023 22:6
    Content type: Research Published on:

  26. The association between body weight variability and the risk of cardiovascular disease (CVD) has been investigated previously with mixed findings. However, there has been no extensive study which systematicall...

    Authors: Robert J. Massey, Moneeza K. Siddiqui, Ewan R. Pearson and Adem Y. Dawed
    Citation: Cardiovascular Diabetology 2023 22:5
    Content type: Research Published on:

  27. Alterations in myocardial mechano-energetic efficiency (MEEi), which represents the capability of the left ventricles to convert the chemical energy obtained by oxidative metabolism into mechanical work, have ...

    Authors: Elena Succurro, Francesco Cicone, Annalisa Papa, Sofia Miceli, Patrizia Vizza, Teresa Vanessa Fiorentino, Maria Perticone, Angela Sciacqua, Pietro Hiram Guzzi, Pierangelo Veltri, Giuseppe Lucio Cascini, Francesco Andreozzi and Giorgio Sesti
    Citation: Cardiovascular Diabetology 2023 22:4
    Content type: Research Published on:

  28. Low-density lipoprotein (LDL)-cholesterol is positively associated with cardiovascular disease (CVD) and inversely associated with type 2 diabetes, which could detract from lipid modification. Here, we examined w...

    Authors: Guoyi Yang and C. Mary Schooling
    Citation: Cardiovascular Diabetology 2023 22:3
    Content type: Research Published on:

  29. Strokes significantly impair quality of life and incur high economic and societal burdens. The triglyceride and glucose (TyG) index is a biochemical marker of insulin resistance (IR) and may have important val...

    Authors: Ying Yang, Xiangting Huang, Yuge Wang, Lin Leng, Jiapei Xu, Lei Feng, Shixie Jiang, Jiang Wang, Yanrong Yang, Gaofeng Pan, Bing Jiang, Yan Wang and Lan Chen
    Citation: Cardiovascular Diabetology 2023 22:2
    Content type: Review Published on:

  30. Heart failure (HF) is a critical complication in elderly patients with atrial fibrillation (AF) and diabetes mellitus (DM). Recent preclinical studies suggested that non-vitamin K antagonist oral anticoagulant...

    Authors: Shu-Man Lin, Peter Pin-Sung Liu, Yu-Kang Tu, Edward Chia-Cheng Lai, Jih-I Yeh, Jin-Yi Hsu, Kashif M. Munir, Carol Chiung-Hui Peng, Huei-Kai Huang and Ching-Hui Loh
    Citation: Cardiovascular Diabetology 2023 22:1
    Content type: Research Published on:

  31. Patients with type 2-diabetes mellitus (T2D), are characterized by visceral and ectopic adipose tissue expansion, leading to systemic chronic low-grade inflammation. As visceral adiposity is associated with se...

    Authors: Etienne Charpentier, Alban Redheuil, Olivier Bourron, Samia Boussouar, Olivier Lucidarme, Mohamed Zarai, Nadjia Kachenoura, Khaoula Bouazizi, Joe-Elie Salem, Guillaume Hekimian, Matthieu Kerneis, Zahir Amoura, Yves Allenbach, Stephane Hatem, Anne-Caroline Jeannin, Fabrizio Andreelli…
    Citation: Cardiovascular Diabetology 2022 21:294
    Content type: Research Published on:

  32. High-density lipoproteins (HDL) comprise particles of different size, density and composition and their vasoprotective functions may differ. Diabetes modifies the composition and function of HDL. We assessed a...

    Authors: Qiao Jin, Eric S. H. Lau, Andrea O. Luk, Claudia H. T. Tam, Risa Ozaki, Cadmon K. P. Lim, Hongjiang Wu, Elaine Y. K. Chow, Alice P. S. Kong, Heung Man Lee, Baoqi Fan, Alex C. W. Ng, Guozhi Jiang, Ka Fai Lee, Shing Chung Siu, Grace Hui…
    Citation: Cardiovascular Diabetology 2022 21:293
    Content type: Research Published on:

  34. High glycemic variability (GV) is a poor prognostic marker in cardiovascular diseases. We aimed to investigate the association of GV with all-cause mortality in patients with acute heart failure (HF).

    Authors: Kyeong-Hyeon Chun, Jaewon Oh, Chan Joo Lee, Jin Joo Park, Sang Eun Lee, Min-Seok Kim, Hyun-Jai Cho, Jin-Oh Choi, Hae-Young Lee, Kyung-Kuk Hwang, Kye Hun Kim, Byung-Su Yoo, Dong-Ju Choi, Sang Hong Baek, Eun-Seok Jeon, Jae-Joong Kim…
    Citation: Cardiovascular Diabetology 2022 21:291
    Content type: Research Published on:

  35. To evaluate the impact of stress hyperglycemia on the in-hospital prognosis in non-surgical patients with heart failure and type 2 diabetes.

    Authors: Yiling Zhou, Li Liu, Hongmei Huang, Nan Li, Jidong He, Heling Yao, Xiaochi Tang, Xiangyang Chen, Shengzhao Zhang, Qingyang Shi, Furong Qu, Si Wang, Miye Wang, Chi Shu, Yuping Zeng, Haoming Tian…
    Citation: Cardiovascular Diabetology 2022 21:290
    Content type: Research Published on:

  36. The mechanisms linking obesity to cardiovascular disease (CVD) are still not clearly defined. Individuals who are overweight or obese often develop insulin resistance, mediation of the association between obes...

    Authors: Xue Tian, Shuohua Chen, Penglian Wang, Qin Xu, Yijun Zhang, Yanxia Luo, Shouling Wu and Anxin Wang
    Citation: Cardiovascular Diabetology 2022 21:289
    Content type: Research Published on:

  37. Metabolic syndrome (MetS) has been proposed as a clinically identifiable high-risk state for the prediction and prevention of cardiovascular diseases and type 2 diabetes mellitus. As a promising “omics” techno...

    Authors: Hao Wang, Youxin Wang, Xingang Li, Xuan Deng, Yuanyuan Kong, Wei Wang and Yong Zhou
    Citation: Cardiovascular Diabetology 2022 21:288
    Content type: Research Published on:

  38. Non-alcoholic fatty liver disease (NAFLD) is a well-known risk factor for cardiovascular (CV) disease (CVD) and mortality. However, whether the progression or regression of NAFLD can increase or decrease the r...

    Authors: Jiyun Park, Gyuri Kim, Hasung Kim, Jungkuk Lee, Sang-Man Jin and Jae Hyeon Kim
    Citation: Cardiovascular Diabetology 2022 21:287
    Content type: Research Published on:

  39. Endothelium function is often impaired in patients with type 2 diabetes. We hypothesized that by improving endothelial function using diastole-synchronized compressions/decompressions (DSCD) to the lower body ...

    Authors: Paul Valensi, Nicolas Barber-Chamoux, Amel Rezki, Céline Lambert, Bruno Pereira, Christian Dualé, Dominique Delmas and Martine Duclos
    Citation: Cardiovascular Diabetology 2022 21:286
    Content type: Research Published on:

  40. The mechanism by which a sodium-glucose cotransporter inhibitor (SGLT2i) induces favorable effects on diabetes and cardiovascular diseases including heart failure (HF) remains poorly understood. Metabolomics i...

    Authors: Satoshi Katano, Toshiyuki Yano, Hidemichi Kouzu, Ryohei Nagaoka, Ryo Numazawa, Kotaro Yamano, Yusuke Fujisawa, Katsuhiko Ohori, Nobutaka Nagano, Takefumi Fujito, Ryo Nishikawa, Wataru Ohwada, Masaki Katayose, Tatsuya Sato, Atsushi Kuno and Masato Furuhashi
    Citation: Cardiovascular Diabetology 2022 21:285
    Content type: Research Published on:

  41. We hypothesize that early events of diabetes and cardiovascular disease continuums would be ongoing and associated in adolescents. We investigated the association between the Insulin Resistance Phenotype and the

    Authors: Janaina Maiana Abreu Barbosa, Antônio Augusto Moura da Silva, Rosangela Fernandes Lucena Batista, Bernadete Jorge Leal Salgado, Joelma Ximenes Prado Teixeira Nascimento, Vanda Maria Ferreira Simões, Maria Jacqueline Silva Ribeiro, Marco Antonio Barbieri, Alexandre Archanjo Ferraro and Cecilia Claudia Costa Ribeiro
    Citation: Cardiovascular Diabetology 2022 21:284
    Content type: Research Published on:

  42. Patients with type 2 diabetes mellitus (T2DM) usually have higher blood viscosity attributed to high blood glucose that can decrease blood supply to the pancreas. A mild increase in blood pressure (BP) has bee...

    Authors: Zhang Xia, Lijuan Song, Dongdong Fang, Wenjun You, Feng Li, Deqiang Zheng, Yuhao Li, Lu Lin, Jingtao Dou, Xin Su, Qi Zhai, Yingting Zuo, Yibo Zhang, Herbert Y. Gaisano, Jiajia Jiang and Yan He
    Citation: Cardiovascular Diabetology 2022 21:283
    Content type: Research Published on:

  43. The risk of severe coronavirus disease 2019 (COVID-19) is increased in people with diabetes, but effects of diabetes type and other risk factors remain incompletely characterized. We studied this in a Swedish ...

    Authors: Robin Kristófi, Johan Bodegard, Viveca Ritsinger, Marcus Thuresson, David Nathanson, Thomas Nyström, Anna Norhammar and Jan W. Eriksson
    Citation: Cardiovascular Diabetology 2022 21:282
    Content type: Research Published on:

  44. Time in range (TIR), a novel proxy measure of glucose control, is found closely related to diabetic microangiopathy and some other chronic complications, but the correlation between TIR and lower limb angiopat...

    Authors: Yinghua Wei, Chunyan Liu, Yanyu Liu, Zhen Zhang, Zhouqin Feng, Xinyi Yang, Juan Liu, Haiyan Lei, Hui Zhou, Qiuyue Shen, Bin Lu, Ping Gu and Jiaqing Shao
    Citation: Cardiovascular Diabetology 2022 21:281
    Content type: Research Published on:

  45. The triglyceride-glucose (TyG) index was significantly related to clinical outcome in patients with cardiovascular disease (CAD) and cerebrovascular disease (CVD). We aim to investigate the association between...

    Authors: Dong Liu, Kaixuan Yang, Hongqiu Gu, Zixiao Li, Yongjun Wang and Yilong Wang
    Citation: Cardiovascular Diabetology 2022 21:280
    Content type: Research Published on:

  46. We aimed to examine the impact of gender and specific type of cardiovascular disease (CVD) diagnosis (ischemic heart disease [IHD], heart failure, peripheral artery disease [PAD] or stroke) on time-to-initiati...

    Authors: Kristian Løkke Funck, Lasse Bjerg, Anders Aasted Isaksen, Annelli Sandbæk and Erik Lerkevang Grove
    Citation: Cardiovascular Diabetology 2022 21:279
    Content type: Research Published on:

  47. Subclinical LV dysfunction (LVD) identifies heart failure (HF) risk in type 2 diabetes mellitus (T2DM). We sought the extent to which clinical scores (ARIC-HF, WATCH-DM), natriuretic peptides (NTpBNP) and trop...

    Authors: Amera Halabi, Elizabeth Potter, Hilda Yang, Leah Wright, Julian W. Sacre, Jonathan E. Shaw and Thomas H. Marwick
    Citation: Cardiovascular Diabetology 2022 21:278
    Content type: Research Published on:

  48. A substantial proportion of type 1 diabetes (T1D) patients free from known cardiovascular disease (CVD) show premature arterial stiffening, with age, blood pressure, and HbA1c—as gold standard of glycemic cont...

    Authors: Simon Helleputte, Patrick Calders, Arthur Rodenbach, Joke Marlier, Charlotte Verroken, Tine De Backer and Bruno Lapauw
    Citation: Cardiovascular Diabetology 2022 21:277
    Content type: Research Published on:

  49. Coronary heart disease (CHD) and type 2 diabetes (T2D) are two complex diseases with complex interrelationships. However, the genetic architecture of the two diseases is often studied independently by the indi...

    Authors: Han Xiao, Yujia Ma, Zechen Zhou, Xiaoyi Li, Kexin Ding, Yiqun Wu, Tao Wu and Dafang Chen
    Citation: Cardiovascular Diabetology 2022 21:276
    Content type: Research Published on:

  50. Migraine is one of the most common primary headache disorders and a well-known risk factor for cardiovascular disorders. We aimed to investigate the association between migraine and major cardiovascular outcom...

    Authors: Dae Young Cheon, Kyungdo Han, Ye Seul Yang, Yerim Kim, Sang-Hwa Lee, Chulho Kim, Jong-Hee Sohn, Mi Sun Oh, Byung-Chul Lee, Minwoo Lee and Kyung-Ho Yu
    Citation: Cardiovascular Diabetology 2022 21:275
    Content type: Research Published on:
journal logo

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Submit manuscript

Annual Journal Metrics

Cardiovascular Diabetology

ISSN: 1475-2840